CONTACT
+91 80 2808 2808
info@biocon.com

News - Posts

Biocon  /  News – Posts

Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency
  • Thu, 03-Nov-2016
  • Posted by: BIOCON
No Comments

Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year
  • Fri, 28-Oct-2016
  • Posted by: BIOCON
No Comments

Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.
  • Thu, 20-Oct-2016
  • Posted by: BIOCON
No Comments

Biocon Appoints Suresh Subramanian as Head of Branded Formulations (India) Business
  • Mon, 19-Sep-2016
  • Posted by: BIOCON
No Comments

Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France
  • Thu, 01-Sep-2016
  • Posted by: BIOCON
No Comments

Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency
  • Thu, 21-Jul-2016
  • Posted by: BIOCON
No Comments

Biocon’s Insulin Glargine Launched in Japan
  • Fri, 15-Jul-2016
  • Posted by: BIOCON
No Comments

Biocon, Quark Announce Initiation of Pivotal Phase II/III Study of QPI-1007 in Rare Eye Disease in India
  • Thu, 23-Jun-2016
  • Posted by: BIOCON
No Comments

Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting
  • Sat, 04-Jun-2016
  • Posted by: BIOCON
No Comments

Biocon’s Insulin Glargine Receives Regulatory Approval in Japan
  • Sat, 28-May-2016
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>